This podcast is designed for property inventory clerks and service providers, presented by InventoryBase Academy
…
continue reading
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
…
continue reading
The Multifamily Tech Gurus Podcast Series brings you the latest real-world experiences of PropTech innovator Kerry W. Kirby and technologist James W. Lancaster. Kerry and Jimmy live on the technology side of the multifamily housing industry. Kerry has built an award-winning company, 365 Connect, that he founded over two decades ago, and Jimmy leads product development at the company. Together, they are on the frontline of managing their team of developers, customers, and all the craziness in ...
…
continue reading
Simple, Interrupted is a podcast about how to evolve in the ever shifting landscape of veterinary medicine and practice management. In each episode you’ll hear from host Mary Schwartz and passion-driven individuals on their ideas, best practices and stories on surviving radical vet industry changes. What’s most important? Having compassion and giving good quality care to your clients. We will provide you with actionable tips on adopting a CareFirst Approach.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Antibody Drug Conjugate Targets Claudin 18.2 to Treat Gastric Cancer with Joe Ferra Elevation Oncology TRANSCRIPT
Joe Ferra, CEO of Elevation Oncology, highlights the unmet needs in gastric cancer and the potential of targeting Claudins, proteins involved in cell adhesion. The current competitive landscape of antibody drug conjugates (ADCs) confirms the promise of a targeted therapy that delivers a cytotoxic drug directly to cancer cells. Targeting Claudin 18.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Antibody Drug Conjugate Targets Claudin 18.2 to Treat Gastric Cancer with Joe Ferra Elevation Oncology
18:01
18:01
Play later
Play later
Lists
Like
Liked
18:01
Joe Ferra, CEO of Elevation Oncology, highlights the unmet needs in gastric cancer and the potential of targeting Claudins, proteins involved in cell adhesion. The current competitive landscape of antibody drug conjugates (ADCs) confirms the promise of a targeted therapy that delivers a cytotoxic drug directly to cancer cells. Targeting Claudin 18.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Role of AI and Pharmacists in Medication Therapy Optimization with Dr. Steve Goldberg DecisionRx and Jamie Wilkey TRANSCRIPT
Dr. Steve Goldberg, physician and Senior Clinical Advisor at DecisionRx, and Dr. Jamie Wilkey, pharmacist and expert on medication therapy optimization, explain that medications are the fourth leading cause of death in the country. They emphasize the need to consider genetic information and pharmacogenomics to design personalized medication plans t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Role of AI and Pharmacists in Medication Therapy Optimization with Dr. Steve Goldberg DecisionRx and Jamie Wilkey
16:23
16:23
Play later
Play later
Lists
Like
Liked
16:23
Dr. Steve Goldberg, physician and Senior Clinical Advisor at DecisionRx, and Dr. Jamie Wilkey, pharmacist and expert on medication therapy optimization, explain that medications are the fourth leading cause of death in the country. They emphasize the need to consider genetic information and pharmacogenomics to design personalized medication plans t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
DIY Versus Using a Provider for Your Apartment Community Websites
24:36
24:36
Play later
Play later
Lists
Like
Liked
24:36
Join Kerry W. Kirby and Jimmy Lancaster, the masterminds behind the Multifamily Tech Gurus Podcast Series, as they discuss the pros and cons of building your own website versus subscribing to an industry-specific platform for apartment community-level marketing. In this episode, they delve into how custom websites can give a property a unique look …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Taking the Guesswork Out of Medical Bills and Providing Patient Payment Options with Ryne Natzke TrustCommerce TRANSCRIPT
Ryne Natzke is the Chief Revenue Officer for TrustCommerce, a Sphere company that facilitates electronic payments in the healthcare industry, helping ensure security and compliance in transactions between patients and providers. Healthcare payments present unique challenges, as patients have varying preferences and are impacted by economic factors …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Taking the Guesswork Out of Medical Bills and Providing Patient Payment Options with Ryne Natzke TrustCommerce
17:50
17:50
Play later
Play later
Lists
Like
Liked
17:50
Ryne Natzke is the Chief Revenue Officer for TrustCommerce, a Sphere company that facilitates electronic payments in the healthcare industry, helping ensure security and compliance in transactions between patients and providers. Healthcare payments present unique challenges, as patients have varying preferences and are impacted by economic factors …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Medical Marketplace for Hospitals and Surgery Centers of Stale or Excess Inventory Saves Money Reduces Waste with Dr. Andrew Dold RevMed TRANSCRIPT
Dr. Andrew Dold, Co-Founder of RevMed, a B2B marketplace for hospitals and ambulatory surgery centers (ASCs) to address the problem of slow-moving or expiring inventory. This medical marketplace allows facilities to recoup lost revenue by listing medical devices for sale and offers purchasing options for smaller facilities. RevMed serves as a middl…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Medical Marketplace for Hospitals and Surgery Centers of Stale or Excess Inventory Saves Money Reduces Waste with Dr. Andrew Dold RevMed
16:12
16:12
Play later
Play later
Lists
Like
Liked
16:12
Dr. Andrew Dold, Co-Founder of RevMed, a B2B marketplace for hospitals and ambulatory surgery centers (ASCs) to address the problem of slow-moving or expiring inventory. This medical marketplace allows facilities to recoup lost revenue by listing medical devices for sale and offers purchasing options for smaller facilities. RevMed serves as a middl…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Unlocking Secrets of the Ocean for Marine-Based Research and Drug Discovery with Ed Esquenazi Sirenas TRANSCRIPT
Ed Esquenazi, Founder and CEO of Sirenas, is exploring the chemistry of marine organisms to accelerate drug discovery. Marine-based scientific elements are still poorly understood but have the potential to produce unique and useful compounds for drug development. There are stark differences between land-based organisms and marine-based organisms, w…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Unlocking Secrets of the Ocean for Marine-Based Research and Drug Discovery with Ed Esquenazi Sirenas
16:36
16:36
Play later
Play later
Lists
Like
Liked
16:36
Ed Esquenazi, Founder and CEO of Sirenas, is exploring the chemistry of marine organisms to accelerate drug discovery. Marine-based scientific elements are still poorly understood but have the potential to produce unique and useful compounds for drug development. There are stark differences between land-based organisms and marine-based organisms, w…
…
continue reading
Kim Perry, Chief Growth Officer at emtelligent, focuses on using medical AI in the prior authorization process to structure unstructured medical text in patient records, making whole record healthcare possible. AI can be used to extract relevant information from faxed or PDF medical records, saving time and improving efficiency over existing manual…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Using Medical AI to Accelerate the Prior Approval Process with Kim Perry emtelligent
19:44
19:44
Play later
Play later
Lists
Like
Liked
19:44
Kim Perry, Chief Growth Officer at emtelligent, focuses on using medical AI in the prior authorization process to structure unstructured medical text in patient records, making whole record healthcare possible. AI can be used to extract relevant information from faxed or PDF medical records, saving time and improving efficiency over existing manual…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Developing Gene Therapy for Friedreich’s Ataxia Cardiomyopathy with Nolan Townsend Lexeo Therapeutics and Jen Farmer FARA TRANSCRIPT
Nolan Townsend, CEO of Lexeo Therapeutics, and Jen Farmer, CEO of FARA, the Friedreich's Ataxia Research Alliance, are working together to better understand and treat Friedreich's Ataxia. This rare genetic condition includes cardiomyopathy and scoliosis. Lexeo Therapeutics is studying gene therapy as a potential treatment for the cardiovascular com…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Developing Gene Therapy for Friedreich’s Ataxia Cardiomyopathy with Nolan Townsend Lexeo Therapeutics and Jen Farmer FARA
18:20
18:20
Play later
Play later
Lists
Like
Liked
18:20
Nolan Townsend, CEO of Lexeo Therapeutics, and Jen Farmer, CEO of FARA, the Friedreich's Ataxia Research Alliance, are working together to better understand and treat Friedreich's Ataxia. This rare genetic condition includes cardiomyopathy and scoliosis. Lexeo Therapeutics is studying gene therapy as a potential treatment for the cardiovascular com…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How Technology Can Streamline Physician Workflow and Improve Patient Care with Dr. Craig Joseph Nordic Global TRANSCRIPT
Dr. Craig Joseph, Chief Medical Officer at Nordic Global, highlights the concerns and challenges healthcare professionals face when using health IT and the clinician burnout related to the administrative burdens of electronic health records. He addresses the obstacles to integrating IT into healthcare workflows, including cost, risk aversion, and r…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How Technology Can Streamline Physician Workflow and Improve Patient Care with Dr. Craig Joseph Nordic Global
23:01
23:01
Play later
Play later
Lists
Like
Liked
23:01
Dr. Craig Joseph, Chief Medical Officer at Nordic Global, highlights the concerns and challenges healthcare professionals face when using health IT and the clinician burnout related to the administrative burdens of electronic health records. He addresses the obstacles to integrating IT into healthcare workflows, including cost, risk aversion, and r…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Multifamily Tech Gurus Streaming Live from Apartmentalize in Philadelphia
16:18
16:18
Play later
Play later
Lists
Like
Liked
16:18
Join Kerry W. Kirby and Jimmy Lancaster, the masterminds behind the Multifamily Tech Gurus Podcast Series, as they broadcast live from the tradeshow floor at the National Apartment Association’s Apartmentalize Conference in the City of Brotherly Love - Philadelphia. Joined by special guest, multifamily industry changemaker Mike Brewer, Founder and …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Promoting Natural Repair of Spinal Cord Injury and Restoration of Central Nervous System Connectivity with Mike Kelly NervGen Pharma TRANSCRIPT
Mike Kelly, CEO of NervGen Pharma, discusses the company's vision to build a startup biotech focused on repairing the central nervous system, helping patients regain function, not just slowing progression. Their first product, NVG-291, is currently in clinical trials for spinal cord injury. The drug candidate aims to promote natural repair by targe…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Promoting Natural Repair of Spinal Cord Injury and Restoration of Central Nervous System Connectivity with Mike Kelly NervGen
16:56
16:56
Play later
Play later
Lists
Like
Liked
16:56
Mike Kelly, CEO of NervGen Pharma, discusses the company's vision to build a startup biotech focused on repairing the central nervous system, helping patients regain function, not just slowing progression. Their first product, NVG-291, is currently in clinical trials for spinal cord injury. The drug candidate aims to promote natural repair by targe…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Developing Recurring Revenue Health and Wellness Products and Services to Optimize Patient Experience and Build Loyalty with Matt Cronin House of Kaizen TRANSCRIPT
Matt Cronin, Founding Partner of House of Kaizen, discusses how patients' changing healthcare expectations are shaped by their experiences with products and services such as Netflix and Amazon Prime. Consumers now expect a longer-term relationship and personalized experiences with their healthcare providers. House of Kaizen emphasizes the importanc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Developing Recurring Revenue Health and Wellness Products and Services to Optimize Patient Experience and Build Loyalty with Matt Cronin House of Kaizen
19:59
19:59
Play later
Play later
Lists
Like
Liked
19:59
Matt Cronin, Founding Partner of House of Kaizen, discusses how patients' changing healthcare expectations are shaped by their experiences with products and services such as Netflix and Amazon Prime. Consumers now expect a longer-term relationship and personalized experiences with their healthcare providers. House of Kaizen emphasizes the importanc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Menin Inhibition Shows Potential for Precision Therapy in AML with Dr. Mollie Leoni Kura Oncology TRANSCRIPT
Dr. Mollie Leoni, Executive Vice President for Clinical Development of Kura Oncology, discusses the company's ziftomenib program, a menin inhibitor for acute myeloid leukemia (AML). The company initially allowed all AML patients to participate in the clinical study, but later found that specific subtypes, such as those with NPM1 mutation or KMT2A r…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Menin Inhibition Shows Potential for Precision Therapy in AML with Dr. Mollie Leoni Kura Oncology
18:16
18:16
Play later
Play later
Lists
Like
Liked
18:16
Dr. Mollie Leoni, Executive Vice President for Clinical Development of Kura Oncology, discusses the company's ziftomenib program, a menin inhibitor for acute myeloid leukemia (AML). The company initially allowed all AML patients to participate in the clinical study, but later found that specific subtypes, such as those with NPM1 mutation or KMT2A r…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Landscape for Controlling Obesity and Lowering Incidence of Related Diseases with Dr. Steffen-Sebastian Bolz Aphaia Pharma TRANSCRIPT
Dr. Steffen-Sebastian Bolz, Chief Scientific Officer of Swiss-based Aphaia Pharma, shines a light on the excitement around weight loss drugs due to the discovery that GLP-1 agonists and points out the shift in the perception of obesity as a root cause of various health issues. Aphaia Pharma's approach involves stimulating hormone production in the …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Landscape for Controlling Obesity and Lowering Incidence of Related Diseases with Dr. Steffen-Sebastian Bolz Aphaia Pharma
21:01
21:01
Play later
Play later
Lists
Like
Liked
21:01
Dr. Steffen-Sebastian Bolz, Chief Scientific Officer of Swiss-based Aphaia Pharma, shines a light on the excitement around weight loss drugs due to the discovery that GLP-1 agonists and points out the shift in the perception of obesity as a root cause of various health issues. Aphaia Pharma's approach involves stimulating hormone production in the …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Healthcare Outcomes When Hospitals Embrace Vertical Farming with Rick Vanzura Freight Farms and Dr. Amber Orman Advent Health TRANSCRIPT
Rick Vanzura, CEO of Freight Farms, and Dr. Amber Orman, Chief Wellness Officer at Advent Health, discuss their partnership in bringing hyperlocal, sustainable food to healthcare facilities. Freight Farms uses modified shipping containers to grow crops, allowing for year-round production with minimal land and water usage. Advent Health recognized t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Healthcare Outcomes When Hospitals Embrace Vertical Farming with Rick Vanzura Freight Farms and Dr. Amber Orman Advent Health
22:28
22:28
Play later
Play later
Lists
Like
Liked
22:28
Rick Vanzura, CEO of Freight Farms, and Dr. Amber Orman, Chief Wellness Officer at Advent Health, discuss their partnership in bringing hyperlocal, sustainable food to healthcare facilities. Freight Farms uses modified shipping containers to grow crops, allowing for year-round production with minimal land and water usage. Advent Health recognized t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Advancements in Gene Therapy for Rare Ocular Disease and Metabolic Disorders with Guang Qu NGGT Corporation TRANSCRIPT
Guang Qu, Co-Founder of NGGT Corporation is focused on developing gene therapy products using dual functional vector strategies. Guang highlights the importance of distinguishing between recessive and dominant mutations in rare diseases and explains how their approach differs from other gene therapy approaches. The two leading indications caused by…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Advancements in Gene Therapy for Rare Ocular Disease and Metabolic Disorders with Guang Qu NGGT Corporation
21:45
21:45
Play later
Play later
Lists
Like
Liked
21:45
Guang Qu, Co-Founder of NGGT Corporation is focused on developing gene therapy products using dual functional vector strategies. Guang highlights the importance of distinguishing between recessive and dominant mutations in rare diseases and explains how their approach differs from other gene therapy approaches. The two leading indications caused by…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Scaffold for Treating Severe Peripheral Artery Disease Below the Knee with Jennifer Jones-McMeans Abbott and Dr. Brian DeRubertis TRANSCRIPT
Jennifer Jones-McMeans, divisional vice president of global clinical affairs at Abbott’s vascular business, and Dr. Brian DeRubertis, a doctor at the New York-Presbyterian Weill Cornell Medical Center, shine a light on peripheral artery disease and critical limb-threatening ischemia where artery blockage restricts blood flow to the lower legs. Abbo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
New Scaffold for Treating Severe Peripheral Artery Disease Below the Knee with Jennifer Jones-McMeans Abbott and Dr. Brian DeRubertis
22:08
22:08
Play later
Play later
Lists
Like
Liked
22:08
Jennifer Jones-McMeans, divisional vice president of global clinical affairs at Abbott’s vascular business, and Dr. Brian DeRubertis, a doctor at the New York-Presbyterian Weill Cornell Medical Center, shine a light on peripheral artery disease and critical limb-threatening ischemia where artery blockage restricts blood flow to the lower legs. Abbo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Developing Essential Tremor and Other CNS Therapies with Marcio Souza Praxis Precision Medicines TRANSCRIPT
Marcio Souza, President and CEO of Praxis Precision Medicines, discusses the challenges in treating central nervous system disorders and is focused on developing life-altering treatments for patients with essential tremor. Current treatments for epilepsy are often broad-based and not specific to the underlying cause of the disease. Praxis is using …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Developing Essential Tremor and Other CNS Therapies with Marcio Souza Praxis Precision Medicines
19:10
19:10
Play later
Play later
Lists
Like
Liked
19:10
Marcio Souza, President and CEO of Praxis Precision Medicines, discusses the challenges in treating central nervous system disorders and is focused on developing life-altering treatments for patients with essential tremor. Current treatments for epilepsy are often broad-based and not specific to the underlying cause of the disease. Praxis is using …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Disrupting The User Experience with Intrusive Website Popups
24:45
24:45
Play later
Play later
Lists
Like
Liked
24:45
Join Kerry W. Kirby and Jimmy Lancaster, the masterminds behind the Multifamily Tech Gurus Podcast Series, as they deep dive into how website popups can interrupt the flow of navigation and content consumption, leading to frustration and a poor user experience. In this episode, they delve into the excessive use of website popups by marketing manage…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Driving Interoperability and Ubiquitous Access to Healthcare Information with Dr. John Blair MedAllies TRANSCRIPT
Dr. John Blair, CEO of MedAllies, was created to address the lack of communication and coordination between healthcare providers and the importance of interoperability in healthcare. While healthcare has become more complicated over the years, with advancements in technology and automation, the lack of reimbursement for coordination of care has con…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Driving Interoperability and Ubiquitous Access to Healthcare Information with Dr. John Blair MedAllies
21:15
21:15
Play later
Play later
Lists
Like
Liked
21:15
Dr. John Blair, CEO of MedAllies, was created to address the lack of communication and coordination between healthcare providers and the importance of interoperability in healthcare. While healthcare has become more complicated over the years, with advancements in technology and automation, the lack of reimbursement for coordination of care has con…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Universal Approach to Cell Therapy Using SNAP-CAR with Dave Mehalick Coeptis Therapeutics TRANSCRIPT
Dave Mehalick, Chairman, Co-Founder, President, and CEO of Coeptis Therapeutics, focuses on developing cell therapies for oncology and respiratory diseases. They aim to create a universal cell therapy that can be used for various types of cancer and move it from a later line of treatment to a frontline therapy. The company has developed a unique CA…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Universal Approach to Cell Therapy Using SNAP-CAR with Dave Mehalick Coeptis Therapeutics
19:11
19:11
Play later
Play later
Lists
Like
Liked
19:11
Dave Mehalick, Chairman, Co-Founder, President, and CEO of Coeptis Therapeutics, focuses on developing cell therapies for oncology and respiratory diseases. They aim to create a universal cell therapy that can be used for various types of cancer and move it from a later line of treatment to a frontline therapy. The company has developed a unique CA…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Unlocking the Power of CRISPR Technology for Drug Development with Ross Bundy CRISPR QC TRANSCRIPT
Ross Bundy, President and CEO of CRISPR QC, shines a light on the current state of CRISPR gene editing technology and how the field has advanced rapidly since the discovery of CRISPR's potential to edit the human genome. The focus of CRISPR technology has primarily been on curing rare and genetic diseases, but there is also potential for targeting …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Unlocking the Power of CRISPR Technology for Drug Development with Ross Bundy CRISPR QC
19:27
19:27
Play later
Play later
Lists
Like
Liked
19:27
Ross Bundy, President and CEO of CRISPR QC, shines a light on the current state of CRISPR gene editing technology and how the field has advanced rapidly since the discovery of CRISPR's potential to edit the human genome. The focus of CRISPR technology has primarily been on curing rare and genetic diseases, but there is also potential for targeting …
…
continue reading
Nicolas Poirier, CEO of OSE Immunotherapeutics, uses immunology and molecular engineering to develop innovative immunotherapies for oncology, inflammation, autoimmune diseases, and organ transplant. The same immune cells, lymphocytes and macrophages, are involved in both immuno-oncology and immuno-inflammation, and OSE aims to re-educate these cell…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Therapeutic Cancer Vaccines with Nicolas Poirier OSE Immunotherapeutics
20:17
20:17
Play later
Play later
Lists
Like
Liked
20:17
Nicolas Poirier, CEO of OSE Immunotherapeutics, uses immunology and molecular engineering to develop innovative immunotherapies for oncology, inflammation, autoimmune diseases, and organ transplant. The same immune cells, lymphocytes and macrophages, are involved in both immuno-oncology and immuno-inflammation, and OSE aims to re-educate these cell…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Moving Beyond Revenue Management to Optimize Apartment Inventory
26:49
26:49
Play later
Play later
Lists
Like
Liked
26:49
Join Kerry W. Kirby and Jimmy Lancaster, the masterminds behind the Multifamily Tech Gurus Podcast Series, as they deep dive into how artificial intelligence can be strategically aligned with marketing and unit inventory to stay in front of high vacancy rates. In this episode, they delve into some of the controversies surrounding revenue management…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Innovative Blood Collection Device Boosts Participation in Decentralized Clinical Trials with Ben Casavant Tasso TRANSCRIPT
Ben Casavant, Co-Founder and CEO of Tasso, focuses on making diagnostics more accessible to patients that allow collection of blood samples at home. Their customers include pharmaceutical companies conducting research and healthcare providers. Using Tasso's technology in decentralized clinical trials allows for easier recruitment, increased patient…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Innovative Blood Collection Device Boosts Participation in Decentralized Clinical Trials with Ben Casavant Tasso
19:18
19:18
Play later
Play later
Lists
Like
Liked
19:18
Ben Casavant, Co-Founder and CEO of Tasso, focuses on making diagnostics more accessible to patients that allow collection of blood samples at home. Their customers include pharmaceutical companies conducting research and healthcare providers. Using Tasso's technology in decentralized clinical trials allows for easier recruitment, increased patient…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
AI-Powered Device Provides Real-Time Screening for Early Detection of Heart Failure Symptoms with Chris Darland Peerbridge Health TRANSCRIPT
Chris Darland, President and CEO of Peerbridge Health, discusses technology breakthroughs that enable early, low-cost detection of heart issues with a cardiac monitor that uses AI to analyze heart rhythms over time to detect patterns that may indicate heart failure. The device is based on ECG technology that drives the Holter monitor and delivers a…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
AI-Powered Device Provides Real-Time Screening for Early Detection of Heart Failure Symptoms with Chris Darland Peerbridge Health
19:13
19:13
Play later
Play later
Lists
Like
Liked
19:13
Chris Darland, President and CEO of Peerbridge Health, discusses technology breakthroughs that enable early, low-cost detection of heart issues with a cardiac monitor that uses AI to analyze heart rhythms over time to detect patterns that may indicate heart failure. The device is based on ECG technology that drives the Holter monitor and delivers a…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Partnering with Retail Pharmacies to Make Blood Testing More Convenient and Accessible Dr. David Stein Babson Diagnostics TRANSCRIPT
Dr. David Stein, CEO and Director of Babson Diagnostics, a healthcare technology company that focuses on putting the patient at the center of the blood testing experience, recognizing the importance of blood testing in informing clinical decisions and monitoring health. They aim to redefine blood testing by eliminating the anxiety and inconvenience…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Partnering with Retail Pharmacies to Make Blood Testing More Convenient and Accessible Dr. David Stein Babson Diagnostics
17:28
17:28
Play later
Play later
Lists
Like
Liked
17:28
Dr. David Stein, CEO and Director of Babson Diagnostics, a healthcare technology company that focuses on putting the patient at the center of the blood testing experience, recognizing the importance of blood testing in informing clinical decisions and monitoring health. They aim to redefine blood testing by eliminating the anxiety and inconvenience…
…
continue reading